Similarly, treatment with the ferroptosis activator (Erastin) not only suppressed tumor volume but also decreased the expression of autophagy-related proteins (ATG5, ATG7, and BECN1), along with increased cell apoptosis (Figs. 10 and 11A,B). This evidence concerns the gene ATG5 and neoplasm.